Analysis of phase 3 myelofibrosis patient outcomes by subgroups shows treatment with pacritinib reduces spleen volume & symptom burden

Press/Media: Press / Media

PeriodDec 7 2015

Media coverage

1

Media coverage

  • TitleAnalysis of phase 3 myelofibrosis patient outcomes by subgroups shows treatment with pacritinib reduces spleen volume & symptom burden
    Media name/outletPharmaBiz
    CountryIndia
    Date12/7/15
    PersonsRuben Mesa